Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien, Taiwan.
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Sci Rep. 2020 Apr 14;10(1):6294. doi: 10.1038/s41598-020-62958-0.
Dengue virus (DENV) infections may cause life-threatening dengue hemorrhagic fever (DHF). Suppressed protective immunity was shown in these patients. Although several hypotheses have been formulated, the mechanism of DENV-induced immunosuppression remains unclear. Previously, we found that cross-reactive antibodies against tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor 1 (death receptor 4 [DR4]) were elicited in DHF patients, and that anti-DR4 autoantibody fractions were elicited by nonstructural protein 1 (NS1) immunizations in experimental mice. In this study, we found that anti-DR4 antibodies could suppress B lymphocyte function in vitro and in vivo. Treatment with the anti-DR4 immunoglobulin (Ig) induced caspase-dependent cell death in immortalized B lymphocyte Raji cells in vitro. Anti-DR4 Igs elicited by NS1 and DR4 immunizations markedly suppressed mouse spleen transitional T2 B (IgMIgD), bone marrow pre-pro-B (B220CD43), pre-B (B220CD43), and mature B cell (B220IgD) subsets in mice. Furthermore, functional analysis revealed that the pre-elicitation of anti-NS1 and anti-DR4 Ig titers suppressed subsequently neutralizing antibody production by immunization with DENV envelop protein. Our data suggest that the elicitation of anti-DR4 titers through DENV NS1 immunization plays a suppressive role in humoral immunity in mice.
登革热病毒(DENV)感染可能导致危及生命的登革出血热(DHF)。这些患者表现出保护性免疫抑制。尽管已经提出了几种假说,但 DENV 诱导免疫抑制的机制仍不清楚。先前,我们发现登革热患者中产生了针对肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体 1(死亡受体 4 [DR4])的交叉反应性抗体,并且实验小鼠中通过非结构蛋白 1(NS1)免疫接种产生了抗-DR4 自身抗体片段。在这项研究中,我们发现抗-DR4 抗体可以在体外和体内抑制 B 淋巴细胞功能。在体外,用抗-DR4 免疫球蛋白(Ig)处理可诱导永生化 B 淋巴细胞 Raji 细胞中的 caspase 依赖性细胞死亡。通过 NS1 和 DR4 免疫接种产生的抗-DR4 Ig 可显著抑制小鼠脾脏过渡性 T2 B(IgM+IgD)、骨髓前前 B(B220+CD43)、前 B(B220+CD43)和成熟 B 细胞(B220+IgD)亚群。此外,功能分析表明,抗-NS1 和抗-DR4 Ig 滴度的预先产生抑制了随后用 DENV 包膜蛋白免疫接种产生的中和抗体产生。我们的数据表明,通过 DENV NS1 免疫接种产生抗-DR4 滴度在小鼠的体液免疫中起抑制作用。